Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Koppikar Utpal Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2023 4 Koppikar Utpal (Director) has filed a Form 4 on C4 Therapeutics, Inc.
Txns: Granted 26,000 options to buy @ $3.61, valued at $93.9k
03/06/2023 4 Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Sold 6,871 shares @ $3.627, valued at $24.9k
02/09/2023 4 Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Sold 2,485 shares @ $5.46, valued at $13.6k
11/18/2022 4 Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Sold 5,172 shares @ $4.49, valued at $23.2k
Sold 1,083 shares @ $4.491, valued at $4.9k
08/18/2022 4 Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Sold 5,940 shares @ $5.035, valued at $29.9k
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/17/2022 4 Koppikar Utpal (Director) has filed a Form 4 on C4 Therapeutics, Inc.
Txns: Granted 41,200 options to buy @ $22.64, valued at $932.8k
03/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/09/2022 4 Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Sold 2,496 shares @ $14.4615, valued at $36.1k
11/19/2021 4 Koppikar Utpal (Director) has filed a Form 4 on Flexion Therapeutics Inc
Txns: Disposed/sold 32,000 options to buy @ $7.82, valued at $250.2k
11/18/2021 4 Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Sold 3,655 shares @ $17.1169, valued at $62.6k
07/12/2021 4 Koppikar Utpal (Director) has filed a Form 4 on Flexion Therapeutics Inc
Txns: Granted 32,000 options to buy @ $7.82, valued at $250.2k
06/09/2021 4 Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Sold 5,820 shares @ $14.06, valued at $81.8k
05/20/2021 4 Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Sold 3,616 shares @ $14.55, valued at $52.6k
03/30/2021 4 Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Sold 1,761 shares @ $14.58, valued at $25.7k
03/04/2021 4 Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Sold 1,461 shares @ $16.74, valued at $24.5k
03/03/2021 4 Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Granted 45,258 shares @ $0
Granted 68,314 options to buy @ $17.105, valued at $1.2M
02/09/2021 4 Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Sold 1,759 shares @ $20.39, valued at $35.9k
11/18/2020 4 Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Sold 1,469 shares @ $19.774, valued at $29k
08/20/2020 4 Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Sold 1,496 shares @ $12.09, valued at $18.1k
06/10/2020 4 Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Sold 3,924 shares @ $10.18, valued at $39.9k
05/20/2020 4 Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Sold 1,428 shares @ $11.22, valued at $16k
03/30/2020 4 Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Sold 1,827 shares @ $9.17, valued at $16.8k
03/03/2020 4 Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Granted 66,875 shares @ $0
Granted 73,750 options to buy @ $12.15, valued at $896.1k
02/10/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/27/2019 4 Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Granted 10,000 shares @ $0
02/08/2019 4 Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Granted 17,063 shares @ $0
Granted 34,125 options to buy @ $38.47, valued at $1.3M
09/11/2018 4 Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Bought 2,000 shares @ $36.8, valued at $73.6k
06/07/2018 4 Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Granted 45,000 shares @ $0
Granted 75,000 options to buy @ $42.3, valued at $3.2M

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy